JPM vs MUC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MUC exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis with a current ratio of 0.11. The stock is severely overvalued relative to its deterministic baselines, trading at $10.79 despite a Graham Number of $7.81 and an intrinsic value of $1.61. Most concerning is the unsustainable dividend payout ratio of 279.13%, indicating that distributions are not supported by earnings. Combined with a bearish technical trend (10/100), the fund appears to be in a precarious position.
Compare Another Pair
Related Comparisons
JPM vs MUC: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and BlackRock MuniHoldings California Quality Fund, Inc. (MUC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.